Document and Entity Information Document Type Document Period End Date Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag CONSOLIDATED BALANCE SHEETS Statement [Table] Statement [Line Items] Statement [Line Items] Assets [Abstract] ASSETS Assets, Current [Abstract] CURRENT ASSETS Cash and Cash Equivalent Cash and cash equivalents Inventory, Net Inventories Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Total Income Taxes Receivable, Current Tax recoverable Assets, Current TOTAL CURRENT ASSETS Operating Lease, Right-of-Use Asset Operating lease right-of-use assets Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Plant and equipment, net Total Deferred Costs, Noncurrent Deferred offering costs Assets Total assets TOTAL ASSETS Liabilities and Equity [Abstract] LIABILITIES AND SHAREHOLDERS' EQUITY Liabilities, Current [Abstract] CURRENT LIABILITIES Operating Lease, Liability, Current Less: Current obligations Operating lease liabilities, current Accrued Liabilities and Other Liabilities Accrued expenses and other liabilities Total Other Liabilities, Current Due to Director Other Liability, Current, Related Party [Extensible Enumeration] Liabilities, Current TOTAL CURRENT LIABILITIES Operating Lease, Liability, Noncurrent Operating lease liabilities, non-current Long term obligations Liabilities TOTAL LIABILITIES Commitments and Contingencies. Commitments and contingencies Common Stock, Value, Issued Ordinary shares, $0.00001 par value; 4,950,000,000 shares authorized, 560,759,740 and 556,800,001 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively Ordinary share capital Preferred Stock, Value, Issued Series A preferred shares, $0.00001 par value, 50,000,000 shares authorized, 780,000 shares issued and outstanding as of June 30, 2026 Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax Accumulated other comprehensive income Equity, Attributable to Parent Balance at ending Balance at beginning Total shareholders' equity Liabilities and Equity TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY Common Stock, Par or Stated Value Per Share Ordinary shares, par value Ordinary shares, par value Common Stock, Shares Authorized Ordinary shares, authorized Authorized shares Common Stock, Shares, Issued Ordinary shares, shares issued Number of shares issued Common Stock, Shares, Outstanding Ordinary shares, shares outstanding Number of shares outstanding Preferred Stock, Par or Stated Value Per Share Series A preferred shares, par value Preferred Stock, Shares Authorized Series A preferred shares, shares authorized Preferred Stock, Shares Issued Series A preferred shares, shares issued Preferred Stock, Shares Outstanding Series A preferred shares, shares outstanding INTERIM CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) Related and Nonrelated Parties [Axis] Related and Nonrelated Parties [Domain] Nonrelated Party [Member] Non Related Party Related Party [Member] Related Party Revenue from Contract with Customer, Excluding Assessed Tax Revenue Cost of Revenue Cost of revenue Gross Profit Gross profit Gross profit Operating Expenses [Abstract] Operating expenses General and Administrative Expense General and administrative expenses Research and Development Expense Research and development expenses Operating Expenses Operating expenses Total operating expenses Operating Income (Loss) Operating profit (loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income (expenses) Other Nonoperating Income (Expense) Other (expenses) income, net Investment Income, Interest Interest income Nonoperating Income (Expense) Other income (expenses), net Total other income (expenses), net Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Profit (loss) before income tax Loss before income tax Income Tax Expense (Benefit) Income tax credit (expense) Net Income (Loss) Attributable to Parent Net loss for the period Net loss Net loss Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive loss, net of tax: Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Foreign currency translation adjustment Change in cumulative foreign currency translation Comprehensive Income (Loss), Net of Tax, Attributable to Parent Comprehensive loss Earnings Per Share, Basic Basic net (loss) income per share (in dollars per share) Weighted Average Number of Shares Outstanding, Basic Basic weighted average number of shares outstanding (in shares) Earnings Per Share, Diluted Diluted net (loss) income per share (in dollars per share) Weighted Average Number of Shares Outstanding, Diluted Diluted weighted average number of shares outstanding (in shares) Interim Consolidated Statement of Changes in Shareholders' Equity Equity Components [Axis] Equity Component [Domain] Preferred Stock [Member] Preferred Shares Common Stock [Member] Ordinary shares Additional Paid-in Capital [Member] Additional paid-in capital Retained Earnings [Member] Accumulated deficits AOCI Attributable to Parent [Member] Accumulative other comprehensive income Increase (Decrease) in Stockholders' Equity [Roll Forward] CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY Shares, Issued Balance at ending (in shares) Balance at beginning (in shares) The gross value of stock issued during the period upon conversion in connection with reverse recapitalization. Stock Issued During Period, Value, Conversion In Connection With Reverse Recapitalization Conversion of Ordinary shares in connection with reverse recapitalization Number of shares issued during the period as a result of the conversion in connection with reverse recapitalization. Stock Issued During Period, Shares, Conversion In Connection With Reverse Recapitalization Conversion of Ordinary shares in connection with reverse recapitalization (in shares) Stock Issued During Period, Value, New Issues Issuance of PIPE units Stock Issued During Period, Shares, New Issues Issuance of PIPE units (in shares) Number of shares issued Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Transaction cost in connection with reverse recapitalization and issuance of PIPE units Adjustment to deferred offering costs Amount of increase (decrease) to additional paid in capital (APIC) resulting from reversal of prior year carve-out tax difference. Adjustments to Additional Paid in Capital, Reversal Of Prior Year Carve-Out Tax Difference Reversal of prior year carve-out tax difference INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Adjustments to reconcile net loss to net cash used in operating activities Depreciation Depreciation expenses Operating Lease, Cost Lease expenses Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities Increase (Decrease) in Inventories Inventories Increase (Decrease) in Prepaid Expense and Other Assets Prepaid expenses and other current assets Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities Accrued expenses and other liabilities Increase (Decrease) in Deferred Income Taxes Deferred tax liabilities Increase (Decrease) in Due to Affiliates Amount due to an affiliate Increase (Decrease) in Operating Lease Liability Operating lease liabilities Increase (Decrease) in Income Taxes Tax refund Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Net cash (used in) operating activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] CASH FLOWS FROM INVESTING ACTIVITIES Payments to Acquire Property, Plant, and Equipment Acquisition of plant and equipment Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Net cash (used in) investing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] CASH FLOWS FROM FINANCING ACTIVITIES Proceeds from Related Party Debt Proceeds from Director Amount of cash inflow received by the entity in connection with a reverse recapitalization. Proceeds From Reverse Recapitalization Proceeds from reverse recapitalization Proceeds from Issuance of Preferred Stock and Preference Stock Proceeds from PIPE units Payments of Stock Issuance Costs Payment of offering cost related to reverse recapitalization Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Net cash provided by (used in) financing activities Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation Effect of change in exchange rate Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation NET INCREASE / (DECREASE) IN CASH AND CASH EQUIVALENTS Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Cash and cash equivalents, end of year Cash and cash equivalents, beginning of year Noncash Investing and Financing Items [Abstract] SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTMENT AND FINANCIAL ACTIVITIES INFORMATION: Right-of-Use Asset Obtained in Exchange for Operating Lease Liability Addition to operating lease right-of-use assets and lease liabilities Amount of deferred offering costs reclassified to additional paid-in capital upon the completion of a business combination. Reclassification of Deferred Offering Costs to Additional Paid-in Capital Upon Business Combination Fair Value of Assets Acquired Assets acquired from reverse recapitalization Liabilities Assumed Liabilities assumed from reverse recapitalization (settled by working capital loan) ORGANIZATION Disclosure of information about organization and basis of presentation. Organization And Basis Of Presentation [Table] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Organization And Basis Of Presentation [Line Items] ORGANIZATION Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] ORGANIZATION SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Disclosure of information about accounting policies. Accounting Policies [Table] Accounting Policies [Table] Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Accounting Policies [Line Items] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES INVENTORIES Inventory, Current [Table] Inventory [Line Items] INVENTORIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Inventory Disclosure [Text Block] INVENTORIES PREPAID EXPENSES AND OTHER CURRENT ASSETS The entire disclosure for prepaid expenses and other current assets. Prepaid Expenses And Other Assets, Current [Text Block] PREPAID EXPENSES AND OTHER CURRENT ASSETS PLANT AND EQUIPMENT, NET Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Line Items] PLANT AND EQUIPMENT, NET SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Property, Plant, and Equipment [Text Block] PLANT AND EQUIPMENT, NET LEASES Lessee, Lease, Description [Table] Lessee, Lease, Description [Line Items] LEASES Lessee, Operating Leases [Text Block] LEASES DEFERRED OFFERING COSTS The entire disclosure for deferred offering costs. Deferred Offering Costs [Text Block] DEFERRED OFFERING COSTS ACCRUED EXPENSES AND OTHER LIABILITIES Accounts Payable and Accrued Liabilities Disclosure [Text Block] ACCRUED EXPENSES AND OTHER LIABILITIES SHARE CAPITAL Stock, Class of Stock [Table] Class of Stock [Line Items] Equity [Text Block] SHARE CAPITAL COMMITMENTS AND CONTINGENCIES Commitments and Contingencies Disclosure [Text Block] COMMITMENTS AND CONTINGENCIES RELATED PARTY TRANSACTION Related Party Transaction [Table] Related Party Transaction [Line Items] RELATED PARTY TRANSACTION Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTION SEGMENT REPORTING Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Table] Segment Reporting, Entity-Wide Information Not Provided as Part of Reportable Segment, Geographical Area, Revenue and Long-Lived Asset [Line Items] Segment Reporting [Text Block] SEGMENT REPORTING SUBSEQUENT EVENTS Subsequent Event [Table] Subsequent Event [Line Items] SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS Basis of Accounting, Policy [Policy Text Block] Basis of preparation and presentation Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Emerging Growth Company Status [policy text block] Emerging Growth Company Status Disclosure of accounting policy for reverse recapitalization. Reverse Recapitalization, Policy [Policy Text Block] Reverse Recapitalization Consolidation, Policy [Policy Text Block] Principles of Consolidation Use of Estimates, Policy [Policy Text Block] Uses of Estimates Disclosure of accounting policy for risks and uncertainties. Risks And Uncertainties, Policy [Policy Text Block] Risk and uncertainties Fair Value of Financial Instruments, Policy [Policy Text Block] Fair Value of Financial Instruments Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Cash and cash equivalents Credit Loss, Financial Instrument [Policy Text Block] Expected credit loss Allowance Inventory, Policy [Policy Text Block] Inventories Property, Plant, and Equipment [Policy Text Block] Plant and Equipment Long-Lived Asset, Excluding Intangible Asset and Goodwill, Impairment and Disposal [Policy Text Block] Impairment of Long-Lived Assets Lessee, Leases [Policy Text Block] Lease Disclosure of accounting policy for statutory reserve. Statutory Reserve, Policy [Policy Text Block] Statutory reserve Revenue from Contract with Customer [Policy Text Block] Revenue Recognition Cost of Goods and Service [Policy Text Block] Cost of revenue Disclosure of accounting policies for general and administrative expenses. General And Administrative Expense, Policy [Policy text Block] General and administrative expenses Research and Development Expense, Policy [Policy Text Block] Research and development Income Tax, Policy [Policy Text Block] Income Taxes Pension and Other Postretirement Plans, Policy [Policy Text Block] Retirement and other post-retirement benefits Foreign Currency Transactions and Translations Policy [Policy Text Block] Translation of foreign currency Comprehensive Income, Policy [Policy Text Block] Comprehensive income (loss) Earnings Per Share, Policy [Policy Text Block] Net (Loss) Income per Share Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of risks New Accounting Pronouncements, Policy [Policy Text Block] Recently Adopted Accounting Pronouncements The tabular disclosure of the Company's direct and indirect interests in its subsidiaries, including the name of each subsidiary, date and place of incorporation, shareholders, percentage of equity ownership, and principal activities. Schedule of Subsidiary Ownership and Principal Activities [Table Text Block] Schedule of direct and indirect interests in the subsidiaries Tabular disclosure of the useful life of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Schedule of Property, Plant and Equipment, Useful Life [Table Text Block] Schedule of estimated useful lives of property and equipment Disaggregation of Revenue [Table Text Block] Schedule of disaggregation of revenue Tabular disclosure of translation of foreign currency. Schedule of Translation of Foreign Currency [Table Text Block] Schedule of translation of amounts Schedules of Concentration of Risk, by Risk Factor [Table Text Block] Schedule of concentration of risks Schedule of Inventory, Current [Table Text Block] Schedule of inventories, net Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Table Text Block] Schedule of prepaid expenses and other current assets Property, Plant, and Equipment [Table Text Block] Schedule of plant and equipment, net Tabular disclosure of lessee operating lease balance sheet disclosures. Lessee, Operating Lease, Balance Sheet Disclosure [Table Text Block] Schedule of operating lease right-of-use assets and lease obligations Lessee, Operating Lease, Liability, to be Paid, Maturity [Table Text Block] Schedule of maturities of lease liabilities Tabular disclosure of supplemental cash flow information for the periods presented related to leases. Schedule Of Cash Flow, Supplemental Disclosures Related To Leases [Table Text Block] Schedule of supplemental cash flow information related to leases Schedule of Accrued Liabilities [Table Text Block] Schedule of accrued expenses and other liabilities Schedule of Related Party Transactions [Table Text Block] Schedule of related party transactions Segment Reporting [Table Text Block] Schedule of respective information by segment Business Combination [Axis] Business Combination [Domain] Represents information pertaining to Horizon Space Acquisition II Corp. Horizon Space Acquisition II Corp [Member] HSPT Represents the information pertaining to SL Bio Ltd. SL Bio Ltd [Member] SL BIO LTD Consolidated Entities [Axis] Consolidated Entities [Domain] Legal Entity [Axis] Legal Entity [Axis] Entity [Domain] Entity [Domain] Class of Warrant or Right, Number of Securities Called by Each Warrant or Right Number of shares per unit Number of stock bought back by the entity at the exercise price or redemption price and cancelled during the period. Stock Redeemed And Cancelled During Period, Shares Number of shares redeemed and cancelled Business Combination, Consideration Transferred, Equity Interest, Share Issued, Number of Shares Aggregate number of shares issued Aggregate par or stated value of authorized nonredeemable common stock (or common stock redeemable solely at the option of the issuer). Common Stock, Value, Authorized Ordinary shares, authorized value The number of common shares issued by the Company as consideration in connection with the First Merger and Second Merger, before the issuance of additional common shares pursuant to the private investment in public equity (PIPE) financing. Common Stock Shares Issued Before PIPE Financing Ordinary shares issued PIPE Financing The number of common shares outstanding by the Company as consideration in connection with the First Merger and Second Merger, before the issuance of additional common shares pursuant to the private investment in public equity (PIPE) financing. Common Stock Shares Outstanding Before PIPE Financing Ordinary shares outstanding PIPE Financing Shares Issued, Price Per Share Share issued price per share Proceeds from Issuance of Private Placement Aggregate gross proceeds Number of ordinary shares included in each unit issued under the financing agreement. Number of Ordinary Shares Per Unit Issued Number of ordinary shares per unit issued Number of preferred shares included in each unit issued under the financing agreement. Number of Preferred Shares Per Unit Issued Number of preferred shares per unit issued Preferred Stock, Convertible, Conversion Ratio Ratio of conversion of preferred share into ordinary share Goodwill Goodwill Ownership [Axis] Ownership [Domain] Represents information pertaining to SL Bio Taiwan. SL Bio Taiwan [Member] SL Bio Taiwan Subsidiary, Ownership Percentage, Parent Percentage of equity ownership (as a percent) Amount of current assets less current liabilities used for day to day operations of business. Working Capital Working capital Accounts Receivable, Credit Loss Expense (Reversal) Bad debt expense Provision for Loan, Lease, and Other Losses Expected credit loss allowance Inventory Write-down Write-downs inventories Long-Lived Asset, Class [Axis] Long-Lived Asset, Class [Domain] Leasehold Improvements [Member] Leasehold improvement Machinery and Equipment [Member] Machinery and equipment Office Equipment [Member] Office equipment Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Property, Plant, and Equipment, Useful Life, Term, Description [Extensible Enumeration] Property, Plant, and Equipment, Useful Life Useful life Impairment of Long-Lived Assets to be Disposed of Impairment of long-lived assets Disaggregation of Revenue [Table] Product and Service [Axis] Product and Service [Domain] Represents information pertaining to exosome concentrate. Exosome Concentrate [Member] Exosome concentrate Represents information pertaining to skin care products. Skin Care Products [Member] Skin care products Represents information pertaining to hair care products. Hair Care Products [Member] Hair care products Customer [Axis] Customer [Domain] Represents information pertaining to corporate customers. Corporate Customers [Member] Corporate Customers Represents information pertaining to retail customers. Retail Customers [Member] Retail Customers Disaggregation of Revenue [Line Items] SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Counterparty Name [Axis] Counterparty Name [Domain] Represents information pertaining to Wang Ching-Dong. Wang Ching Dong [Member] Mr.Wang Represents information pertaining to SL Link Co., Ltd. SL Link Co., Ltd. [Member] SL Link Co., Ltd. Represents the information pertaining to CytoArm Co Ltd. Cytoarm Co Ltd [Member] CytoArm Represents the information pertaining to CD-19 Armed-T products. Cd 19 Armed T Products [Member] CD-19 Armed-T products Percentage of ownership interest held. Percentage Of Ownership Interest Ownership interest (as a percent) Related Party Transaction, Amounts of Transaction Amount The total consideration, including value-added tax, payable under the agreement. Total Consideration for Agreement Total consideration for agreement The amount paid for research and development activities during the reporting period. Payments for Research and Development Payments for research and development The amount paid for research and development activities during the reporting period. Payments Made for Agreements Payments made for agreements The remaining consideration payable under the agreement upon satisfaction of specified conditions and milestones. Remaining Consideration Under Agreement Remaining consideration Percentage of royalty to be paid on sales. Percentage Of Royalty Percentage of royalty The amount of patent application fees, patent maintenance fees, and project development fees payable or reimbursable by the Group under the license agreement as of the reporting date. Patent and Project Development Fees Payable Patent and project development fees payable Represents information pertaining to chief technical officer. Chief Technical Officer [Member] CTO Represents information pertaining to Ji Yan BioMedical Co., Ltd. Ji Yan BioMedical Co., Ltd [Member] JY BioMed Represents information pertaining to HeXun Biosciences Co., Ltd. HeXun Biosciences Co., Ltd [Member] HeXun Represents information pertaining to new product pipeline. New Product Pipeline [Member] New product pipeline Represents the information pertaining to pancreatic cancer products. Pancreatic Cancer Products [Member] Pancreatic cancer products Represents the information pertaining to brain cancer products. Brain Cancer Products [Member] Brain cancer products Number of license agreements. Number of License Agreements Number of license agreement The period of license agreement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Term of License Agreement License period Threshold written notice period for termination of the agreement, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Threshold Written Notice Period For Termination Of Agreement Notice period for termination of agreement Threshold period for correction of material breach, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Threshold Period For Correction Of Material Breach Threshold period for correction of material breach Amount of initial consideration paid under GDT Cells License Agreements. Initial Consideration, Amount Paid Initial consideration paid Amount of total consideration paid or payable under GDT Cells License Agreements. Total Consideration Total consideration The remaining amount of consideration to be paid under GDT Cells License Agreements. Remaining Amount of Consideration Remaining consideration Amounts paid under the agreement upon meeting up conditions and milestones. Amount Paid Upon Meeting on Conditions and Milestones Amount paid under agreement Pension and Other Postretirement Benefits Cost (Reversal of Cost) Employee benefit expenses Foreign Currency Exchange Rate, Translation Years ended NTD: US$1 exchange rate Average foreign exchange rate used to translate amounts denominated in functional currency to reporting currency. Average Foreign Currency Exchange Rate, Translation Annual average NTD: US$1 exchange rate Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Potentially dilutive shares Concentration Risk [Table] Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Domain] Cost of Goods and Service Benchmark [Member] Purchase Revenue from Contract with Customer Benchmark [Member] Sales Concentration Risk Type [Axis] Concentration Risk Type [Domain] Supplier Concentration Risk [Member] Vendor Customer Concentration Risk [Member] Customer Supplier [Axis] Supplier [Domain] Represents the information pertaining to vendor A. Vendor A [Member] Vendor A Represents the information pertaining to customer A. CustomerA [Member] Customer A Represents the information pertaining to customer B. Customer B [Member] Customer B Concentration Risk [Line Items] Concentration of risks Concentration Risk, Percentage Concertation risk (in percent) Accounts Receivable, after Allowance for Credit Loss, Current Accounts receivable Inventory, Finished Goods, Net of Reserves Finished goods Value Added Tax Receivable, Current Value added tax credit Other Receivables, Net, Current Other receivable Carrying amount as of the balance sheet date of security deposits receivable classified as current. Security Deposits Receivable, Current Security deposits Prepaid Taxes Prepaid income tax Amount of consideration paid in advance for operating expenses that provide economic benefits within a future period of one year or the normal operating cycle, if longer. Prepaid Operating Expenses, Current Prepaid operating expenses Provision for Other Credit Losses Expected credit loss provision Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization Property and equipment, gross Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization Less: accumulated depreciation Tangible Asset Impairment Charges Impairment Amount of Operating lease expenses. Operating Lease, Expenses Operating lease cost Short-Term Lease, Cost Short-term lease cost Lessee, Operating Lease, Remaining Lease Term Remaining lease terms Operating Lease, Weighted Average Remaining Lease Term Weighted average remaining lease term Operating Lease, Weighted Average Discount Rate, Percent Weighted average discount rate There is no custom definition. Operating Lease, Asset [Abstract] Assets Operating Lease, Liability [Abstract] Liabilities Operating Lease, Liability Total lease liabilities Operating Lease, Payments Operating cash outflows from operating assets Accrued Liabilities, Current Accrued expenses Carrying value as of the balance sheet date of obligations incurred through that date and payable for audit fees. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Accrued Audit Fees, Current Accrued audit fee Accrued Payroll Taxes, Current Accrued staff costs Other Accrued Liabilities, Current Others Amount of authorized share capital. Authorized Share Capital Authorized share capital Number of shares authorized including ordinary shares and preferred shares. Number of Shares Authorized Number of shares authorized Number of votes for each share. Number of Vote Per Share Number of votes per share Number of units issuable under the subscription agreement. Number Of Units Issuable Number of units issuable Per unit amount of units issuable. Units Issuable, Price Per Unit Price per unit of unit issuable Gorss value of units issuable under the subscription agreement. Gross Value Of Units Issuable Gross value of units issuable Number of common shares issuable per unit. Common Stock, Number Of Shares Per Unit Number of ordinary shares issuable per unit Number of preferred shares issuable per unit. Preferred Stock, Number Of Shares Per Unit Number of preferred shares issuable per unit Represents the number of the Company's common shares exchanged for each share of the accounting acquirer's common stock in a reverse recapitalization. Reverse Recapitalization, Exchange Ratio Number of shares issued before giving effect of reverse recapitalization. Common Stock Shares Issued Before Effect of Reverse Recapitalization Number of shares issued Number of shares outstanding before giving effect of reverse recapitalization. Common Stock Shares Outstanding Before Effect of Reverse Recapitalization Number of shares outstanding Number of shares issued of reverse recapitalization. Reverse Recapitalization Issuance of Shares Issuance of shares Related Party Transaction [Axis] Related Party Transaction [Domain] Represents information pertaining to payment of research and development costs. Payment Of Research And Development Costs [Member] Payment of research and development costs Represents the information pertaining to Mr. Wang. Mr. Wang [Member] Mr. Wang Other Liabilities Due to Director Other Liability, Related Party [Extensible Enumeration] Other Liability, Related Party [Extensible Enumeration] Segments [Axis] Segments [Domain] Represents the information pertaining to Exosome Products segment. Exosome Products Segment [Member] Exosome Products Represents the information pertaining to CD-19 Armed-T Products segment. CD-19 Armed-T Products Segment [Member] CD-19 Armed-T Products Represents the information pertaining to GDT cell therapy Products segment. GDT cell therapy Products Segment [Member] GDT cell therapy Products Consolidation Items [Axis] Consolidation Items [Domain] Operating Segments [Member] Operating segments Represents the aggregate total of non operating corporate items and reconciling items. Corporate and Reconciling Items [Member] Corporate and Unallocated Indicates (true false) whether the reportable segments were disclosed by definition. Number Of Reportable Segments Disclosed By Definition Flag Long-Lived Asset, Excluding Financial Instrument, Customer Relationship, Mortgage Servicing Right, Deferred Policy Acquisition Cost, and Deferred Tax Asset, Amount Identifiable long-lived assets Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent events Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period Expiration period Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Authorized Ordinary shares Represents the maximum number of shares issuable as percentage of issued share capital in a share based payment arrangement. Share Based Compensation Arrangement By Share Based Payment Award, Maximum Shares Issuable As Percentage Of Issued Capital Issued share capital (as a percent) Percentage of annual increase in the shares to be issued under share based payment arrangement. Share Based Compensation Arrangement By Share Based Payment Award, Share Limit, Annual Increase, Percentage Of Shares Outstanding Outstanding ordinary shares (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross Awarded shares Debt Instrument, Face Amount Aggregate loan amount Repayments of Related Party Debt Repayments of loan